Comprehensive Clinical Evaluation Study of GLP-1RA
Recruiting
Observational Study
T2DM
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 492 (estimated)
- Sponsor
- LI YAN · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The objective of this project is to identify the most efficacious glucagon-like peptide-1 receptor agonists (GLP-1RAs) for the treatment of adult patients with type 2 diabetes mellitus (T2DM). In accordance with the index system and evaluation rules set forth in the Management Guidelines for Comprehensive Clinical Evaluation of Drugs, the effects of GLP-1RAs drugs in real-world settings are tracke…
Trial Locations
Sorted by distance from Kentucky
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosed with type 2 diabetes;
* no study drug has been used in the last three months;
* Existing hypoglycemic programs include investigational drugs;
* Age ≥18 years old;
* The patient's demographic data, disease history, course records, laboratory test indicators, drug use …
Contacts
Dong Zhonghua The First Affiliated Hospital of Shandong First Medical Univer, master
+8618253161252
CONTACT